NeuroSense Therapeutics NRSN
NASDAQ NRSN
$2.56 +0.17 (+7.11%)
At close: Oct 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Receivables - Net (2020 - 2023)

Updated

NeuroSense Therapeutics (NRSN) recorded Receivables - Net of $236,000 in Q4 2023, down 7.5% from $255,000 a year earlier.

Analysis

NeuroSense Therapeutics (NRSN) Receivables - Net (2020 - 2023) Analysis & Trends

Starting with Q4 2020, NeuroSense Therapeutics' Receivables - Net history includes 4 quarters.

  • Annual Receivables - Net has a three-year compound annual growth rate of 98.9% (FY2020 to FY2023).
  • Across earlier years, Receivables - Net came in at $255,000 in FY2022 (-17.7%), $310,000 in FY2021 (+933.3%) and $30,000 in FY2020.
  • The Q4 2023 figure is the lowest quarterly Receivables - Net since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 NeuroSense Therapeutics 3.19 Mn -1.26 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 236,000.00
Dec 31, 2022 255,000.00
Dec 31, 2021 310,000.00
Dec 31, 2020 30,000.00
API Access

NeuroSense Therapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=NRSN&period=max&api_key=YOUR_API_KEY